BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IDE892 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of IDE892\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07277413-2536@assetmemo.bio
DTSTAMP:20261121T004510Z
DTSTART;VALUE=DATE:20280430
DTEND;VALUE=DATE:20280501
SUMMARY:IDE892: Phase 1 readout est. (NCT07277413)
DESCRIPTION:IDE892\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Study 
 of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tu
 mors\nEstimated primary completion: 30 April 2028. This is a ClinicalTrial
 s.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pag
 e: https://assetmemo.bio/drug/ide892#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT07277413
URL:https://assetmemo.bio/drug/ide892#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
